TOCAGEN
Tocagen is a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating primary tumors and metastatic diseases. The company's products comprise Prodrug Activator product candidates for treating glioblastoma multiforme; and immunotherapeutic product candidates for treating metastatic malignant melanoma. Tocagen was founded in 2007 and is based in San Diego, California.
TOCAGEN
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2007-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.tocagen.com
Total Employee:
101+
Status:
Closed
Contact:
8584128499
Total Funding:
168.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving IPv6 ReCAPTCHA Microsoft Azure DNS GoDaddy DNS Google Google Cloud
Current Employees Featured
Founder
Stock Details
Investors List
Whiz Partners
Whiz Partners investment in Post-IPO Equity - Tocagen
Official Site Inspections
http://www.tocagen.com
- Host name: 195.35.60.52
- IP address: 195.35.60.52
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Tocagen"
Tocagen - Crunchbase Company Profile & Funding
Tocagen is a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating primary tumors and metastatic …See details»
Tocagen Company Profile 2024: Valuation, Investors, Acquisition
Tocagen Inc is a clinical-stage, cancer-selective gene therapy company. It is focused on developing product candidates designed to activate a patient's immune system against their …See details»
Tocagen Inc. - Company Profile & Staff Directory - ContactOut
We are driven by a vision to end cancer mortality. Our company was founded on this vision in 2007. Tocagen’s mission is to become a leading biopharmaceutical company for the treatment …See details»
SEC.gov | HOME
Organization Consolidation And Presentation Of Financial Statements [Abstract] ... (“Forte Subsidiary”) a private entity, and Tocagen, Inc. (“Tocagen”), a publicly traded biotechnology …See details»
Tocagen - Ownership and Business Overview - Mergr
Tocagen is a fully integrated global biotech company that develops first-in-class, broadly applicable, product candidates, that are designed to activate a patient’s immune system …See details»
Tocagen, Inc. - Drug pipelines, Patents, Clinical trials
Explore Tocagen, Inc. with its drug pipeline, therapeutic area, technology platform, 8 clinical trials, 8 news, and 57 literature, Disease Domain:Nervous System Diseases, Neoplasms, Technology Platform:Monoclonal antibody, …See details»
Tocagen - Products, Competitors, Financials, Employees, …
Jan 12, 2024 Tocagen is a biotechnology company focused on developing cancer-selective gene therapies for the treatment of brain cancer. The company's main offerings include a …See details»
Tocagen Inc.: Contact Details and Business Profile
We are driven by a vision to end cancer mortality. Our company was founded on this vision in 2007. Tocagen’s mission is to become a leading biopharmaceutical company for the treatment …See details»
TOCAGEN INC Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TOCAGEN INC of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Forte Biosciences, Inc. completed the acquisition of Tocagen Inc.
Jun 14, 2020 As per filing on April 23, 2020, immediately after the merger, it is currently estimated that Forte's equity holders will own approximately 76.7% of the common stock of the …See details»
Tocagen - Funding, Financials, Valuation & Investors - Crunchbase
Tocagen is registered under the ticker NASDAQ:TOCA . Their stock opened with $10.00 in its Apr 13, 2017 IPO. Stock Symbol NASDAQ:TOCA ; Valuation at IPO $185M; Money Raised at IPO …See details»
Tocagen - Company Profile - Tracxn
Nov 5, 2024 Tocagen ranks 967th among 2850 active competitors. 1028 of its competitors are funded while 655 have exited. Overall, Tocagen and its competitors have raised over $96.3B …See details»
Tocagen - Updates, News, Events, Signals & Triggers - Crunchbase
Tocagen is a biopharmaceutical company developing gene therapy products for the treatment of cancer.See details»
Tocagen Inc. Management Team | Org Chart - RocketReach
Tocagen Inc. employs 54 employees. The Tocagen Inc. management team includes Doug Jolly (Founder, Executive Vice President, Research and Pharmaceutical Development), Victoria …See details»
Tocagen Inc. (TOCA) Profile, Company FAQs & Facts ... - Stocktwits
Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against …See details»
Forte Biosciences, Inc. Announces Closing of Merger With Tocagen
Jun 15, 2020 To Commence Trading on Nasdaq Capital Market on June 16, 2020 Under Ticker Symbol “FBRX” Forte Biosciences, Inc. (NASDAQ: FBRX), a clinical-stage biopharmaceutical …See details»
Tocagen restructuring leads to reverse merger with Forte
Feb 20, 2020 Dive Brief: Cancer biotech Tocagen will merge with the privately held Forte Biosciences, bringing its decade-plus run as an independent company to a close some four …See details»
Tocagen - Contacts, Employees, Board Members, Advisors & Alumni
Tocagen has 6 current employee profiles, including Vice President, Corporate Strategy and Business Development Nicholas A. Boyle. Nicholas A. Boyle Vice President, Corporate …See details»
Tocagen – $98 Million IPO // Cooley // Global Law Firm
San Diego – April 20, 2017 – Cooley advised Tocagen on its $97.8 million initial public offering of 9,775,000 shares of common stock. San Diego-based Tocagen, which trades on The …See details»
Working at Tocagen: 7 Reviews - Indeed
Reviews from Tocagen employees about Tocagen culture, salaries, benefits, work-life balance, management, job security, and more ... -Position- I began w/ Tocagen over 6 months ago and …See details»